Skip to content

Total debt at other companies

Globus Medical logo
Globus MedicalGMED
$116.26M+25.0%
Solventum logo
SolventumSOLV
$5.79B-26.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
AbbVie logo
AbbVieABBV
Stryker logo
StrykerSYK
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Calculated from Establishment Labs’s reported figures.

Plus components not separately reported this period.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's total debt?
Establishment Labs (ESTA) reported total debt of $252.71M in Q1 2026.
How has Establishment Labs's total debt changed year-over-year?
Establishment Labs's total debt increased by 12.0% year-over-year, from $225.7M to $252.71M.
What is the long-term trend for Establishment Labs's total debt?
Over 5 years (2020 to 2025), Establishment Labs's total debt has grown at a 36.7% compound annual growth rate (CAGR), from $52.89M to $252.05M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.